Shaohua Wu, Li Ma, Jingrong Wang, Xiaolian Wen, Meijing Zheng, Bing Xu, Hongling Ma, Yanli Wang, Liping Su. "Orelabrutinib plus rituximab-based chemoimmunotherapy regimens in relapsed or refractory marginal zone lymphoma: A multicentric phase II trial." Blood (2025). https://doi.org/10.1182/blood-2025-7117